Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Cue Biopharma, Inc.
Cue Biopharma Inc is a biopharmaceutical company developing a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders.
IPO Date: January 2, 2018
Sector: Healthcare
Industry: Biotech
Market Cap: $52.74M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.27 | 3.77%
Avg Daily Range (30 D): $0.03 | 4.68%
Avg Daily Range (90 D): $0.04 | 4.64%
Institutional Daily Volume
Avg Daily Volume: .23M
Avg Daily Volume (30 D): .33M
Avg Daily Volume (90 D): .19M
Trade Size
Avg Trade Size (Sh.): 120
Avg Trade Size (Sh.) (30 D): 407
Avg Trade Size (Sh.) (90 D): 335
Institutional Trades
Total Inst.Trades: 183
Avg Inst. Trade: $2.16M
Avg Inst. Trade (30 D): $.62M
Avg Inst. Trade (90 D): $.62M
Avg Inst. Trade Volume: .22M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.18M
Avg Closing Trade (30 D): $.62M
Avg Closing Trade (90 D): $.62M
Avg Closing Volume: 243.1K
   
News
Jul 23, 2025 @ 1:26 PM
High‑Growth Oncology Market Projected For U...
Source: Prnewswire
Jun 24, 2025 @ 8:48 PM
Cue Biopharma Receives FDA Feedback on Pre-IND Bri...
Source: N/A
Apr 15, 2025 @ 2:23 AM
Cue Biopharma Announces Pricing of Approximately $...
Source: Globe Newswire
Apr 15, 2025 @ 2:23 AM
Cue Biopharma Announces Pricing of Approximately $...
Source: N/A
Apr 14, 2025 @ 9:00 PM
Boehringer Ingelheim and Cue Biopharma partner to ...
Source: N/A
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-.64 $-.17 $-.1
Diluted EPS $-.64 $-.17 $-.1
Revenue $ 7.99M $ .42M $ 1.58M
Gross Profit $ $ $
Net Income / Loss $ -40.58M $ -12.26M $ -9.5M
Operating Income / Loss $ -41.13M $ -12.3M $ -9.63M
Cost of Revenue $ $ $
Net Cash Flow $ -27.89M $ -9.32M $ -9.96M
PE Ratio